NCT00550446 - A Phase 2 Study For Patients With A Physician's Diagnosis Of Rheumatoid Arthritis | Biotech Hunter

Enrollment

386

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions

Arthritis, Rheumatoid

Interventions

DRUG

Adalimumab

40mg subcutaneous injections every other week for 6 injections during week 0-10 with oral placebo BID. Subjects switched to CP-690,550 at week 12.

DRUG

CP-690-550

15 mg BID oral plus 6 placebo subcutaneous injections (week 0-10)

DRUG

CP-690-550

10 mg BID oral plus 6 placebo subcutaneous injections (week 0-10)

DRUG

CP-690-550

5 mg BID oral plus 6 placebo subcutaneous injections (week 0-10)

DRUG

CP-690,550

3 mg BID PO plus 6 placebo subcutaneous injections (week 0-10)

DRUG

CP-690,550

1 mg BID PO plus 6 placebo subcutaneous injections (week 0-10)

DRUG

Placebo

Placebo by mouth plus 6 placebo subcutaneous injections (week 0-10)

Trial Locations (63)

1612

Pfizer Investigational Site, Sofia

1709

Pfizer Investigational Site, Sofia

5800

Pfizer Investigational Site, Pleven

10000

Pfizer Investigational Site, Zagreb

11527

Pfizer Investigational Site, Goudi

16132

Pfizer Investigational Site, Genova

16635

Pfizer Investigational Site, Duncansville

21000

Pfizer Investigational Site, Split

21018

Pfizer Investigational Site, Vinnitsa

22081

Pfizer Investigational Site, Hamburg

28601

Pfizer Investigational Site, Hickory

28602

Pfizer Investigational Site, Hickory

31134

Pfizer Investigational Site, Hildesheim

32804

Pfizer Investigational Site, Orlando

33614

Pfizer Investigational Site, Tampa

44650

Pfizer Investigational Site, Guadalajara

45408

Pfizer Investigational Site, Dayton

50139

Pfizer Investigational Site, Florence

52140

Pfizer Investigational Site, Metepec

60053

Pfizer Investigational Site, Morton Grove

61000

Pfizer Investigational Site, Kharkiv

61107

Pfizer Investigational Site, Rockford

62270

Pfizer Investigational Site, Cuernavaca

67203

Pfizer Investigational Site, Wichita

67208

Pfizer Investigational Site, Wichita

69118

Pfizer Investigational Site, Zaporizhzhia

70115

Pfizer Investigational Site, New Orleans

72205

Pfizer Investigational Site, Little Rock

75150

Pfizer Investigational Site, Mesquite

75235

Pfizer Investigational Site, Dallas

79011

Pfizer Investigational Site, Lviv

85208

Pfizer Investigational Site, Mesa

91325

Pfizer Investigational Site, Northridge

91356

Pfizer Investigational Site, Tarzana

91786

Pfizer Investigational Site, Upland

94304

Pfizer Investigational Site, Palo Alto

94305

Pfizer Investigational Site, Stanford

700661

Pfizer Investigational Site, Iași

900591

Pfizer Investigational Site, Constanța

7530206

Pfizer Investigational Site, Providencia

8331030

Pfizer Investigational Site, Santiago

8360156

Pfizer Investigational Site, Santiago

52401-2112

Pfizer Investigational Site, Cedar Rapids

37909-1600

Pfizer Investigational Site, Knoxville

90035-903

Pfizer Investigational Site, Porto Alegre

01323-903

Pfizer Investigational Site, São Paulo

Unknown

Pfizer Investigational Site, Sofia

656 91

Pfizer Investigational Site, Brno

128 50

Pfizer Investigational Site, Prague

140 59

Pfizer Investigational Site, Prague

148 00

Pfizer Investigational Site, Praha 11 - Chodov

760 01

Pfizer Investigational Site, Zlín

01067

Pfizer Investigational Site, Dresden

04103

Pfizer Investigational Site, Leipzig

54 636

Pfizer Investigational Site, Thessaloniki

H-5000

Pfizer Investigational Site, Szolnok

06100

Pfizer Investigational Site, México

011172

Pfizer Investigational Site, Bucharest

921 12

Pfizer Investigational Site, Piešťany

012 07

Pfizer Investigational Site, Žilina

110-744

Pfizer Investigational Site, Seoul

133-792

Pfizer Investigational Site, Seoul

04114

Pfizer Investigational Site, Kyiv